Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines"

Comment

Miao-Yan Wei et al. Ann Surg. 2021.

. 2021 Dec 1;274(6):e769-e770.

doi: 10.1097/SLA.0000000000004291.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
Schulick RD, Oba A, Del Chiaro M. Schulick RD, et al. Ann Surg. 2021 Dec 1;274(6):e770-e771. doi: 10.1097/SLA.0000000000004275. Ann Surg. 2021. PMID: 33074877 No abstract available.

Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines.
Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Oba A, et al. Ann Surg. 2022 Jan 1;275(1):175-181. doi: 10.1097/SLA.0000000000003859. Ann Surg. 2022. PMID: 32149822

1. Oba A, Croce C, Hosokawa P, et al. Prognosis based definition of resectability in pancreatic cancer: a road map to new guidelines. Ann Surg 2020.
1. Demir IE, Jager C, Schlitter AM, et al. R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer. Ann Surg 2018; 268:1058–1068.
1. He C, Zhang Y, Cai Z, et al. Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: a competing risk nomogram analysis. J Cancer 2018; 9:3156–3167.
1. Klaiber U, Hackert T, Neoptolemos JP. Adjuvant treatment for pancreatic cancer. Transl Gastroenterol Hepatol 2019; 4:27.
1. Oba A, Ho F, Bao QR, et al. Neoadjuvant treatment in pancreatic cancer. Front Oncol 2020; 10:245.